Läubli Lab / Cancer ImmunotherapyHead of Research Unit Prof. Dr. med. Dr. sc. nat. Heinz Läubli, Prof. Dr. med. Dr. sc. nat.OverviewMembersPublicationsProjects & CollaborationsProjects & Collaborations OverviewMembersPublicationsProjects & Collaborations Projects & Collaborations 12 foundShow per page10 10 20 50 Collaboration with Glycocalyx Therapeutics Research Project | 1 Project MembersImported from Grants Tool 4724648 Reimbursement of ACT Research Project | 1 Project MembersDevelop understanding of reimbursement options of innovative therapies. Exploring a Novel Immune Resilience: Unraveling Avenues in Immunotherapy Research Project | 1 Project MembersImported from Grants Tool 4704967 The role fucosylation in anti-tumor immunity and a new fucosidase-based approach to treat cancer Research Project | 1 Project MembersImported from Grants Tool 4694544 Targeting sialoglycan-mediated immune suppression for cancer therapy Research Project | 1 Project MembersNo Description available Discovery and functional assessment of antagonistic antibodies Research Project | 1 Project MembersNo Description available Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancer Research Project | 1 Project MembersNo Description available Glycoera Service Contract Research Project | 1 Project MembersNo Description available T-OP / Training Network for Optimizing Adoptive T cell Therapy of Cancer Research Project | 2 Project MembersAdoptive T cell therapy, which employs the patient's own cells as a weapon, is considered a breakthrough in the treatment of cancer. However, the production of such immunotherapy products lacks harmonisation with clinical studies. The EU-funded T-OP project aims to bridge this gap by bringing together interdisciplinary teams of scientists working in cell therapy, immunology, protein engineering and bioinformatics alongside large and medium-sized enterprises. The scientific work will focus on cytokines and their role in the therapeutic outcome of adoptive cell therapy, aiming to determine the optimal combination. The project's results will lead to the development of safer and improved immunotherapeutics. Novel cancer therapeutics targeting carbohydrate antigens Research Project | 1 Project MembersNo Description available 12 12 OverviewMembersPublicationsProjects & Collaborations
Projects & Collaborations 12 foundShow per page10 10 20 50 Collaboration with Glycocalyx Therapeutics Research Project | 1 Project MembersImported from Grants Tool 4724648 Reimbursement of ACT Research Project | 1 Project MembersDevelop understanding of reimbursement options of innovative therapies. Exploring a Novel Immune Resilience: Unraveling Avenues in Immunotherapy Research Project | 1 Project MembersImported from Grants Tool 4704967 The role fucosylation in anti-tumor immunity and a new fucosidase-based approach to treat cancer Research Project | 1 Project MembersImported from Grants Tool 4694544 Targeting sialoglycan-mediated immune suppression for cancer therapy Research Project | 1 Project MembersNo Description available Discovery and functional assessment of antagonistic antibodies Research Project | 1 Project MembersNo Description available Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancer Research Project | 1 Project MembersNo Description available Glycoera Service Contract Research Project | 1 Project MembersNo Description available T-OP / Training Network for Optimizing Adoptive T cell Therapy of Cancer Research Project | 2 Project MembersAdoptive T cell therapy, which employs the patient's own cells as a weapon, is considered a breakthrough in the treatment of cancer. However, the production of such immunotherapy products lacks harmonisation with clinical studies. The EU-funded T-OP project aims to bridge this gap by bringing together interdisciplinary teams of scientists working in cell therapy, immunology, protein engineering and bioinformatics alongside large and medium-sized enterprises. The scientific work will focus on cytokines and their role in the therapeutic outcome of adoptive cell therapy, aiming to determine the optimal combination. The project's results will lead to the development of safer and improved immunotherapeutics. Novel cancer therapeutics targeting carbohydrate antigens Research Project | 1 Project MembersNo Description available 12 12
Collaboration with Glycocalyx Therapeutics Research Project | 1 Project MembersImported from Grants Tool 4724648
Reimbursement of ACT Research Project | 1 Project MembersDevelop understanding of reimbursement options of innovative therapies.
Exploring a Novel Immune Resilience: Unraveling Avenues in Immunotherapy Research Project | 1 Project MembersImported from Grants Tool 4704967
The role fucosylation in anti-tumor immunity and a new fucosidase-based approach to treat cancer Research Project | 1 Project MembersImported from Grants Tool 4694544
Targeting sialoglycan-mediated immune suppression for cancer therapy Research Project | 1 Project MembersNo Description available
Discovery and functional assessment of antagonistic antibodies Research Project | 1 Project MembersNo Description available
Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancer Research Project | 1 Project MembersNo Description available
T-OP / Training Network for Optimizing Adoptive T cell Therapy of Cancer Research Project | 2 Project MembersAdoptive T cell therapy, which employs the patient's own cells as a weapon, is considered a breakthrough in the treatment of cancer. However, the production of such immunotherapy products lacks harmonisation with clinical studies. The EU-funded T-OP project aims to bridge this gap by bringing together interdisciplinary teams of scientists working in cell therapy, immunology, protein engineering and bioinformatics alongside large and medium-sized enterprises. The scientific work will focus on cytokines and their role in the therapeutic outcome of adoptive cell therapy, aiming to determine the optimal combination. The project's results will lead to the development of safer and improved immunotherapeutics.
Novel cancer therapeutics targeting carbohydrate antigens Research Project | 1 Project MembersNo Description available
